•  Nasdaq

  •  OTC BB


    ProPhase Labs (PRPH) Rejected the Revised and Unsolicited Non-Binding Proposal from Matrixx Initiatives to Be Acquired for $1.60 per Share

    October 29 Oct 2012 | 13:02


    http://pennyomega.com/img/prph.jpg PRPH, ProPhase Labs, Inc.

    ** PRPH reported that it has rejected the revised and unsolicited, non-binding proposal from Matrixx Initiatives, Inc. (“Matrixx”) to acquire the Company for $1.60 per share in cash.

    This most recent proposal, like their prior $1.40 per share proposal, is conditioned on further due diligence by Matrixx.


    PRPH is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE(R) Cold Remedy brand as well as other cold relief products.

    More about PRPH at www.ProPhaseLabs.com.


    Read Full Disclaimer at http://CRWENews.com/disclaimer

    Tags: , ,



     CRWE Network